Early therapeutics development with phase II emphasis

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200622007C
Awardee
Awarding agency
Obligated
$2,509,264

Award facts

Opportunity
  • N01CM5701816 Solicitation number
Contract value 12% obligated
  • $14,254,686.57 Current, with exercised options
  • $20,352,600.57 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 11 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Columbus, OH 43210, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 18 · Modified to deogligate funds that remained at contract closure and close the contract. -$1
Change Order 17 $55,133
Other Administrative Action 16 $0
Other Administrative Action 15 · Other functions the purpose of this modification is to extend the arra portion of this contract through october 31, 2011. $0
Other Administrative Action 14 $0
Other Administrative Action 13 $0
Other Administrative Action 12 · The purpose of this modification is to extend the arra portion of this contract through october 31, 2011. $0
Funding Only Action 11 $58,305
Other Administrative Action 10 $46,644
Exercise an Option 9 · Biomedical (basic) $106,871
Funding Only Action 8 · Recovery act - actnow clinical trial 8472 under "early therapeutics development with phase II emphasis" arra::yes::arra $754,737
Exercise an Option 7 $123,123
Other Administrative Action 6 $345,648
Funding Only Action 5 $203,665
Funding Only Action 4 $100,000
Funding Only Action 3 $62,007
Funding Only Action 2 $145,460
Other Administrative Action 1 $102,479
Original award $405,192
Show all 19

About this award

Written by GovTribe AI ·

This is a federal contract award issued by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to The Ohio State University Research Foundation. The contract, valued at $20,352,600.57, is for early therapeutic development with a Phase II emphasis. It is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of October 31, 2012. The Ohio State University Research Foundation is a U.S. state government entity and 1862 Land Grant College that provides technical, engineering, and biomedical research services to the federal government through prime and subcontract awards. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract HHSN261200622007C?

HHSN261200622007C was awarded to The Ohio State University Research Foundation by National Cancer Institute (National Institutes of Health) on January 1, 2006.

How much is contract HHSN261200622007C worth?

The government has obligated $2,509,264 on HHSN261200622007C. Its current value, with exercised options, is $14,254,687. Its potential value, with all options, is $20,352,601.

Was contract HHSN261200622007C competed?

The extent of competition for HHSN261200622007C was full and open competition. The government received 11 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login